Avatars and empathy: The use of video games to affect prejudicial evaluations of African Americans

This research sought to test the relation between video game avatars (online representations of the self), empathy, social dominance orientation, and prejudice. By having participants imagine playing in a game as an avatar I sought to test three hypotheses. Th first hypothesis proposed that that participants would be more inclined to support policies regarding a specific racial group when imagining play as an avatar representing that group. The second hypothesis proposed that empathy would influence the connection between the avatar and participant race variables. The third, which was split into three parts, tested for a negative correlation between prejudice and empathy, whether high levels of social dominance would suppress the beneficial effects of the counter-race avatar (specifically for White participants), and whether prejudicial judgments would be higher for participants high in social dominance orientation regardless of the race of participant or avatar condition. Participant prejudice and empathy were assessed with an empathy test from DeWall and Baumeister (2006) and the Social Dominance Orientation Scale. The hypothesis that high levels of social dominance would suppress the effect of the counter-race avatar was partially supported for positive assessments of race when controlling for social dominance orientation. Additionally, it was expected that White participants high in empathy would have stronger effects than White participants low in empathy or compared to participants of color and that social dominance orientation (SDO) would be negatively correlated with empathy. Results for empathy were not supported, however, the results for the association of SDO and prejudice were

Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.

Osteocytes are master regulators of the skeleton. We mapped the transcriptome of osteocytes from different skeletal sites, across age and sexes in mice to reveal genes and molecular programs that control this complex cellular-network. We define an osteocyte transcriptome signature of 1239 genes that distinguishes osteocytes from other cells. 77% have no previously known role in the skeleton and are enriched for genes regulating neuronal network formation, suggesting this programme is important in osteocyte communication. We evaluated 19 skeletal parameters in 733 knockout mouse lines and reveal 26 osteocyte transcriptome signature genes that control bone structure and function. We showed osteocyte transcriptome signature genes are enriched for human orthologs that cause monogenic skeletal disorders (P = 2.4 × 10-22) and are associated with the polygenic diseases osteoporosis (P = 1.8 × 10-13) and osteoarthritis (P = 1.6 × 10-7). Thus, we reveal the molecular landscape that regulates osteocyte network formation and function and establish the importance of osteocytes in human skeletal disease

Characterizing Hospital Workers' Willingness to Respond to a Radiological Event

Terrorist use of a radiological dispersal device (RDD, or "dirty bomb"), which combines a conventional explosive device with radiological materials, is among the National Planning Scenarios of the United States government. Understanding employee willingness to respond is critical for planning experts. Previous research has demonstrated that perception of threat and efficacy is key in the assessing willingness to respond to a RDD event.An anonymous online survey was used to evaluate the willingness of hospital employees to respond to a RDD event. Agreement with a series of belief statements was assessed, following a methodology validated in previous work. The survey was available online to all 18,612 employees of the Johns Hopkins Hospital from January to March 2009.Surveys were completed by 3426 employees (18.4%), whose demographic distribution was similar to overall hospital staff. 39% of hospital workers were not willing to respond to a RDD scenario if asked but not required to do so. Only 11% more were willing if required. Workers who were hesitant to agree to work additional hours when required were 20 times less likely to report during a RDD emergency. Respondents who perceived their peers as likely to report to work in a RDD emergency were 17 times more likely to respond during a RDD event if asked. Only 27.9% of the hospital employees with a perception of low efficacy declared willingness to respond to a severe RDD event. Perception of threat had little impact on willingness to respond among hospital workers.Radiological scenarios such as RDDs are among the most dreaded emergency events yet studied. Several attitudinal indicators can help to identify hospital employees unlikely to respond. These risk-perception modifiers must then be addressed through training to enable effective hospital response to a RDD event

2020 roadmap on solid-state batteries

Li-ion batteries have revolutionized the portable electronics industry and empowered the electric vehicle (EV) revolution. Unfortunately, traditional Li-ion chemistry is approaching its physicochemical limit. The demand for higher density (longer range), high power (fast charging), and safer EVs has recently created a resurgence of interest in solid state batteries (SSB). Historically, research has focused on improving the ionic conductivity of solid electrolytes, yet ceramic solids now deliver sufficient ionic conductivity. The barriers lie within the interfaces between the electrolyte and the two electrodes, in the mechanical properties throughout the device, and in processing scalability. In 2017 the Faraday Institution, the UK's independent institute for electrochemical energy storage research, launched the SOLBAT (solid-state lithium metal anode battery) project, aimed at understanding the fundamental science underpinning the problems of SSBs, and recognising that the paucity of such understanding is the major barrier to progress. The purpose of this Roadmap is to present an overview of the fundamental challenges impeding the development of SSBs, the advances in science and technology necessary to understand the underlying science, and the multidisciplinary approach being taken by SOLBAT researchers in facing these challenges. It is our hope that this Roadmap will guide academia, industry, and funding agencies towards the further development of these batteries in the future

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Genome-wide association studies (GWAS) have identified numerous common prostate cancer (PrCa) susceptibility loci. We have fine-mapped 64 GWAS regions known at the conclusion of the iCOGS study using large-scale genotyping and imputation in 25 723 PrCa cases and 26 274 controls of European ancestry. We detected evidence for multiple independent signals at 16 regions, 12 of which contained additional newly identified significant associations. A single signal comprising a spectrum of correlated variation was observed at 39 regions; 35 of which are now described by a novel more significantly associated lead SNP, while the originally reported variant remained as the lead SNP only in 4 regions. We also confirmed two association signals in Europeans that had been previously reported only in East-Asian GWAS. Based on statistical evidence and linkage disequilibrium (LD) structure, we have curated and narrowed down the list of the most likely candidate causal variants for each region. Functional annotation using data from ENCODE filtered for PrCa cell lines and eQTL analysis demonstrated significant enrichment for overlap with bio-features within this set. By incorporating the novel risk variants identified here alongside the refined data for existing association signals, we estimate that these loci now explain ∼38.9% of the familial relative risk of PrCa, an 8.9% improvement over the previously reported GWAS tag SNPs. This suggests that a significant fraction of the heritability of PrCa may have been hidden during the discovery phase of GWAS, in particular due to the presence of multiple independent signals within the same regio

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Interactions between ice and ocean observed with phase-sensitive radar near an Antarctic

ice-shelf grounding lin